UroGen Pharma Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 02/17/2026 | 4.54 M | $106.42 M | 0.00% | 9.46% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 4.47 M | $104.77 M | 6.11% | 9.31% |
| BLACKROCK, INC. | 02/12/2026 | 2.60 M | $60.92 M | 0.76% | 5.41% |
| MORGAN STANLEY | 02/13/2026 | 2.56 M | $60.02 M | 1.36% | 5.33% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 2.20 M | $51.52 M | 0.00% | 4.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 1.74 M | $40.72 M | 10.24% | 3.62% |
| ACORN CAPITAL ADVISORS, LLC | 02/17/2026 | 1.45 M | $33.92 M | 14.98% | 3.01% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 1.38 M | $32.26 M | 19.03% | 2.87% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 1.36 M | $31.82 M | 100.00% | 2.83% |
| MENORA MIVTACHIM HOLDINGS LTD. | 02/12/2026 | 1.15 M | $26.99 M | 0.00% | 2.40% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/13/2026 | 1.13 M | $26.35 M | 100.00% | 2.34% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 1.00 M | $23.42 M | 0.00% | 2.08% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 962.62 K | $22.54 M | 8.29% | 2.00% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 941.38 K | $22.05 M | 597.32% | 1.96% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 875.49 K | $20.50 M | 27.07% | 1.82% |
| STATE STREET CORP | 02/13/2026 | 807.42 K | $18.91 M | -1.47% | 1.68% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 02/17/2026 | 781.62 K | $18.31 M | 100.00% | 1.63% |
| MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. | 01/28/2026 | 770.91 K | $18.06 M | 0.00% | 1.60% |
| CITADEL ADVISORS LLC | 02/17/2026 | 737.76 K | $17.28 M | 22.49% | 1.54% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/17/2026 | 718.35 K | $16.82 M | 717.13% | 1.49% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 717.35 K | $16.80 M | 0.00% | 1.49% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 618.95 K | $14.50 M | -57.86% | 1.29% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 616.61 K | $14.44 M | 72.91% | 1.28% |
| J. GOLDMAN & CO LP | 02/17/2026 | 513.30 K | $12.02 M | 100.00% | 1.07% |
| WOODLINE PARTNERS LP | 02/17/2026 | 500.73 K | $11.73 M | 63.44% | 1.04% |
| BOXER CAPITAL MANAGEMENT, LLC | 02/17/2026 | 500.00 K | $11.71 M | -13.04% | 1.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 475.21 K | $11.13 M | 0.85% | 0.99% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 459.72 K | $10.77 M | 8.19% | 0.96% |
| VANGUARD GROUP INC | 01/29/2026 | 439.75 K | $10.30 M | 44.76% | 0.92% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 435.49 K | $10.20 M | -36.65% | 0.91% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 366.68 K | $8.59 M | 125.98% | 0.76% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 350.00 K | $8.20 M | -65.00% | 0.73% |
| NUVEEN, LLC | 02/12/2026 | 302.60 K | $7.09 M | -40.38% | 0.63% |
| RICE HALL JAMES & ASSOCIATES, LLC | 02/17/2026 | 281.88 K | $6.60 M | 8.77% | 0.59% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 268.42 K | $6.29 M | 100.00% | 0.56% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 244.30 K | $5.72 M | -11.20% | 0.51% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 241.21 K | $5.65 M | -37.54% | 0.50% |
| NORTHERN TRUST CORP | 02/17/2026 | 237.46 K | $5.56 M | -9.16% | 0.49% |
| UBS GROUP AG | 01/29/2026 | 235.04 K | $5.50 M | 30.24% | 0.49% |
| ATOM INVESTORS LP | 02/17/2026 | 234.42 K | $5.49 M | -19.71% | 0.49% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/03/2026 | 214.62 K | $5.03 M | 9.15% | 0.45% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 168.77 K | $3.95 M | -58.08% | 0.35% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 166.90 K | $3.91 M | -54.86% | 0.35% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 162.73 K | $3.81 M | 10.53% | 0.34% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/14/2026 | 161.92 K | $3.79 M | 148.41% | 0.34% |
| EAM INVESTORS, LLC | 02/12/2026 | 160.41 K | $3.76 M | 100.00% | 0.33% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 153.41 K | $3.59 M | -24.87% | 0.32% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 150.00 K | $3.51 M | -77.91% | 0.31% |
| JPMORGAN CHASE & CO | 02/11/2026 | 146.27 K | $3.43 M | -72.64% | 0.30% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 136.02 K | $3.19 M | 346.20% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
UroGen Pharma Ltd institutional Ownership - FAQ's
During the previous two years, 215 institutional investors and hedge funds held shares of UroGen Pharma Ltd. The most heavily invested institutionals were:
SG Americas Securities, LLC: 1.66 M
Privium Fund Management B.V.: 238,122
UBS Group AG: 159,658
Aisling Capital Management LP: 108,000
Bank of New York Mellon Corp: 98,942
Nuveen, LLC: 87,522
90.96% of UroGen Pharma Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 51.58 M shares in the last 24 months. This purchase volume represents approximately $1.03 B in transactions.